Pfizer Inc. is a global pharmaceutical company that is renowned for its research, development, and manufacturing of innovative healthcare products. Founded in 1849 by Charles Pfizer and Charles Erhart, the company has grown to become one of the largest pharmaceutical companies in the world. Pfizer is listed on the New York Stock Exchange (NYSE) under the ticker symbol "PFE" and is also a component of the Dow Jones Industrial Average.
Pfizer's primary focus is on discovering, developing, and manufacturing prescription medicines and vaccines across a wide range of therapeutic areas, including oncology, immunology, cardiology, and neuroscience. The company has a robust pipeline of drugs under development and continues to invest in research and development to address unmet medical needs.
One exceptionally noteworthy achievement of Pfizer is the development of the COVID-19 vaccine in partnership with BioNTech. The Pfizer-BioNTech COVID-19 vaccine, also known as Comirnaty, was granted emergency use authorization in various countries around the world. It has played a crucial role in the global efforts to combat the COVID-19 pandemic and has been administered to millions of people worldwide.
Pfizer's portfolio includes numerous medicines that have made significant contributions to healthcare. Some of its notable products include Lipitor (atorvastatin), a widely prescribed medication for reducing cholesterol levels; Viagra (sildenafil), a well-known treatment for erectile dysfunction; and Prevnar 13 (pneumococcal 13-valent conjugate vaccine), a vaccine that protects against several strains of pneumococcal bacteria.
The company operates in various markets globally, serving healthcare professionals, patients, and consumers. It collaborates with healthcare providers, governments, and other stakeholders to ensure the accessibility and affordability of its medicines and vaccines. Pfizer is committed to improving global health and addresses public health challenges through its research, partnerships, and access programs.
In addition to its pharmaceutical business, Pfizer also has a division called Upjohn that focuses on manufacturing and marketing a portfolio of off-patent branded and generic established medicines. This division aims to make quality medicines more accessible and affordable to patients worldwide.